This study is looking at whether ovarian platelet-rich plasma (PRP) injections can improve the quality of embryos for women experiencing infertility, poor ovarian reserve, or embryo growth disorders. PRP is a treatment where your own blood is processed to concentrate platelets, which are then injected into your ovaries. Researchers will compare embryo development before and after PRP treatment in the same patient using special AI software and time-lapse imaging. To join, you must be a woman between 18 and 47 years old, have adequate ovarian reserves (AMH level), and be willing to undergo two IVF (in vitro fertilization) cycles and PRP treatment. The main goal is to see if PRP improves blastocyst formation and embryo quality after one year.

Study design

This is an interventional study planning to enroll 180 women. It is not specified if it is randomized or blinded.

What's involved

You will undergo an initial IVF cycle, followed by two ovarian PRP injections and a second IVF cycle. Embryo development will be analyzed using AI software.

Compensation

Not stated in the trial record.

Follow-up

Embryo quality will be measured at 1 year after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.